# Effect of Sertraline on Inflammation in Hemodialysis Patients with Depression: a Randomized Controlled Trial

> **NCT06840379** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Nishtar Medical University** · enrollment: 62 (actual)

## Conditions studied

- Inflamation
- Hemodialysis
- End Stage Renal Disease on Hemodialysis (Diagnosis)

## Interventions

- **DRUG:** Sertraline (Oral Antidepressant)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06840379
- **Lead sponsor:** Nishtar Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06840379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06840379, "Effect of Sertraline on Inflammation in Hemodialysis Patients with Depression: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06840379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*